期刊文献+

我院96例抗结核药品不良反应报告分析 被引量:7

The analysis of adverse drug reactions report of 96 cases with tuberculosis in our hospital
下载PDF
导出
摘要 目的:探讨一线抗结核药物的各种不良反应及其发生的相关因素,为临床合理用药提供参考。方法:对我院2004-2008年肺结核病患者在抗结核病治疗中出现了不良反应的96例患者的临床资料进行回顾性分析。结果:患者的性别、年龄与药物不良反应的发生有关,不良反应以肝功能损害、胃肠道反应、关节痛等较为常见。结论:抗结核药物的不良反应发生率较高,以肝功能损害为最常见。 Objective: To investigate the adverse reactions and their related factors of the first-line anti-TB drugs to provide a ref- erence for clinical rational use of drugs. Methods: Retrospective method was used to analyze the Clinical data of 96 TB patients who received the anti-tuberculosis treatment and had adverse reactions in our hospitals between 2004 and 2008 .Results: The patient's sex and age were related to the occurrence of adverse drug reactions. Among the adverse reactions, liver damage, gastrointestinal reactions and joint pain were more common, Conclusion: The anti-TB drugs had a higher incidence of adverse reactions and the liver function damage was the most common one.
作者 翟新文
出处 《中国中医药咨讯》 2010年第16期53-54,共2页
关键词 抗结核药 结核 不良反应 anti-TB drugs tuberculosis adverse reactions
  • 相关文献

参考文献4

二级参考文献16

  • 1贾辅忠.喷诺酮类药物及其临床应用现状[J].中国实用内科杂志,1994,14(3):179-180. 被引量:53
  • 2杨松,张耀亭,殷建团.复方甘草甜素对结核药物性肝炎的预防作用研究[J].临床肺科杂志,2006,11(1):45-46. 被引量:10
  • 3孙德庆,结核病的化学疗法,1987年,5页
  • 4王光超,皮肤病及性病学,1962年,89页
  • 5Hussain Z, Kar P, Husain SA. Antituberculosis drug-induced hepatitis: risk factors, prevention and management. Indian J Exp Biol,2003,41 : 1226-1232.
  • 6Onnerod LP, Horsfleld N. Frequency and type of reactions to antituberculosis drugs: observations in routine treatment. Tuber Lung Dis, 1996,77:37-42.
  • 7Maria VA, Victorino RM. Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis. Hepatology, 1997,26,664-669.
  • 8Danan G, Benichou C, Flahault A. Score of suspected drug-induced acute liver disorders. Presentation of an evaluation sheet. Gastroenterol Clin Biol, 1993,17 ( 5 pt 2 ) : H22-H24.
  • 9Iwasa M ,Zeniya M,Kumagi T,et al. Modified diagnostic criteria of drug-induced liver injury proposed by the intemational consensus meeting, Hepatogastroenteroloty,2005,52:869-874.
  • 10Durand F, Jebrak G, Pessayre D, et al. Hepatotoxicity of antitubercular treatments. Rationale for monitoring liver status. Drug Saf, 1996,15 : 394-405.

共引文献346

同被引文献44

引证文献7

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部